A Prospective, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating Meniscal Healing, Clinical Outcomes, and Safety in Patients Undergoing Meniscal Repair of Unstable, Complete Vertical Meniscal Tears (Bucket Handle) Augmented with Platelet-Rich Plasma

Table 2

Baseline characteristics of the study patients in the control and PRP-treated groups.

	Control group; ()	PRP-treated group; ()	value
Age (years)	26 (19–44)	30 (18–43)
Sex (M : F)	15 : 3	15 : 4
Time from injury (months)	3 (1–10)	2 (1–8)
Education (high school : college/university)	10 : 8	12 : 7
VAS score	5.06 ± 0.13 (4–6.11)	6.21 ± 0.13 (5.13–7.29)
IKDC score	41.7 ± 0.84 (34.7–48.69)	40.92 ± 0.92 (33.09–48.74)
WOMAC	38.61 ± 1.19 (28.74−48.49)	32.26 ± 0.90 (24.55–39.97)	= 0.25
KOOS
(i) Pain	55.15 ± 1.04 (46.49–63.81)	58.81 ± 0.83 (51.68–65.94)
(ii) Symptoms	44.84 ± 1.13 (35.44–54.25)	51.88 ± 1.15 (42.08–61.68)
(iii) ADL	58.95 ± 1.34 (47.81–70.09)	66.68 ± 0.95 (58.55–74.81)
(iv) Sport/recreation	24.44 ± 1.73 (10.03–38.86)	25.53 ± 1.32 (14.29–36.76)
(v) QOL	22.57 ± 0.91 (15.02–30.12)	27.19 ± 0.76 (20.68–33.71)

Data are presented as median (range) or mean ± standard error (95% confidence interval) unless otherwise indicated; PRP, platelet-rich plasma; VAS, visual analog scale; IKDC, International Knee Documentation Committee; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index; KOOS, Knee Injury and Osteoarthritis Outcome Score; ADL, activities of daily living; QOL, quality of life.